PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1109367
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1109367
North-America age-related macular degeneration (AMD) market is projected to register a CAGR of 8.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
North-America Age-Related Macular Degeneration (AMD) Market, By Types (Dry AMD and Wet AMD), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others) and Distribution Channel (Direct Tender and Retail Sales) Industry Trends and Forecast to 2029.
Growing geriatric population
Growing prevalence of macular degeneration
Novartis AG
Bayer AG
REGENXBIO Inc.
Ionis Pharmaceutics
Ocugen Inc
Johnson & Johnson Services, Inc
IVERIC bio
MeiraGTx Limited
Adverum Biotechnologies, Inc.
Graybug Vision Inc.
Kodiak Sciences Inc.
Genentech Inc.